BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25502723)

  • 1. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism.
    Yuan L; Liu X
    Mol Med Rep; 2015 Apr; 11(4):2449-58. PubMed ID: 25502723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer.
    Gu A; Jie Y; Yao Q; Zhang Y; Mingyan E
    Reprod Sci; 2017 Feb; 24(2):291-299. PubMed ID: 27368877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.
    Hu Q; Hisamatsu T; Haemmerle M; Cho MS; Pradeep S; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Wong STC; Sood AK; Afshar-Kharghan V
    Clin Cancer Res; 2017 Sep; 23(18):5611-5621. PubMed ID: 28611202
    [No Abstract]   [Full Text] [Related]  

  • 4. Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
    Yang M; Zou J; Zhu H; Liu S; Wang H; Bai P; Xiao X
    Oncol Rep; 2015 May; 33(5):2190-8. PubMed ID: 25760800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.
    Wang Y; Liu P; Wang X; Mao H
    Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.
    Orellana R; Kato S; Erices R; Bravo ML; Gonzalez P; Oliva B; Cubillos S; Valdivia A; Ibañez C; Brañes J; Barriga MI; Bravo E; Alonso C; Bustamente E; Castellon E; Hidalgo P; Trigo C; Panes O; Pereira J; Mezzano D; Cuello MA; Owen GI
    BMC Cancer; 2015 Apr; 15():290. PubMed ID: 25886038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
    Zhang GM; Sui LH; Jia T; Zhao YZ; Fu SB; Liu XH; Yu Y
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):170-3. PubMed ID: 18756929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.
    Holmes CE; Levis JE; Ornstein DL
    Clin Exp Metastasis; 2009; 26(7):653-61. PubMed ID: 19444623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression.
    Erices R; Cubillos S; Aravena R; Santoro F; Marquez M; Orellana R; Ramírez C; González P; Fuenzalida P; Bravo ML; Oliva B; Kato S; Ibañez C; Brañes J; Bravo E; Alonso C; García K; Arab C; Torres VA; Godoy AS; Pereira J; Bustos G; Cardenas JC; Cuello MA; Owen GI
    Oncotarget; 2017 Mar; 8(13):20865-20880. PubMed ID: 28209916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
    Xiao X; Yang M; Xiao J; Zou J; Huang Q; Yang K; Zhang B; Yang F; Liu S; Wang H; Bai P
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):807-18. PubMed ID: 24638862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant hirudin suppresses the viability, adhesion, migration and invasion of Hep-2 human laryngeal cancer cells.
    Lu Q; Lv M; Xu E; Shao F; Feng Y; Yang J; Shi L
    Oncol Rep; 2015 Mar; 33(3):1358-64. PubMed ID: 25592110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin promotes ovarian cancer angiogenesis and metastasis.
    Zhu M; Fejzo MS; Anderson L; Dering J; Ginther C; Ramos L; Gasson JC; Karlan BY; Slamon DJ
    Gynecol Oncol; 2010 Nov; 119(2):337-44. PubMed ID: 20688362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients.
    Sinha D; Chong L; George J; Schlüter H; Mönchgesang S; Mills S; Li J; Parish C; Bowtell D; Kaur P;
    Clin Cancer Res; 2016 Apr; 22(7):1813-24. PubMed ID: 26589433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Selectin-Mediated Adhesion between Platelets and Tumor Cells Promotes Intestinal Tumorigenesis in Apc(Min/+) Mice.
    Qi C; Li B; Guo S; Wei B; Shao C; Li J; Yang Y; Zhang Q; Li J; He X; Wang L; Zhang Y
    Int J Biol Sci; 2015; 11(6):679-87. PubMed ID: 25999791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab‑resistant ovarian cancer model.
    Su F; Geng J; Li X; Qiao C; Luo L; Feng J; Dong X; Lv M
    Oncol Rep; 2017 Nov; 38(5):2677-2684. PubMed ID: 29048687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential platelet levels affect response to taxane-based therapy in ovarian cancer.
    Bottsford-Miller J; Choi HJ; Dalton HJ; Stone RL; Cho MS; Haemmerle M; Nick AM; Pradeep S; Zand B; Previs RA; Pecot CV; Crane EK; Hu W; Lutgendorf SK; Afshar-Kharghan V; Sood AK
    Clin Cancer Res; 2015 Feb; 21(3):602-10. PubMed ID: 25473001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.